Anxiety Clinical Trials in Chicago

Showing 21-40 of 66 trials

Integrating a Suite of Mental Health Apps for Depression in a Healthcare Setting

NCT05274620

The purpose of this study is to evaluate the implementation of IntelliCare as a frontline intervention within health care settings.

DepressionAnxiety

Adaptive Health, Inc82 participantsStarted May 2022

Chicago, Illinois, United States • Florence, South Carolina, United States

COMPLETEDNA2.2 miles

Memory and Fear Study (Fear of Memory Loss Study)

NCT04821960

This study is a randomized control study to determine the impact of a tailored, web-based mindfulness program to reduce anxiety and increase the quality of life in older adults experiencing dementia-related fears, relative to a conventional meditation program.

Anxiety and Fear

Northwestern University81 participantsStarted May 2021

Chicago, Illinois, United States

COMPLETEDNA2.2 miles

Positive Affect Regulation sKills at Northwestern University

NCT04367922

The Positive Affect Regulation sKills (PARK) Course is an online program containing a series of positive emotion skills for individuals experiencing stress and distress as a result of COVID-19 and the return to "normal." The study specifically targets positive emotion, and offers an array of skills in a self-guided online delivery platform, making the program accessible and convenient in confusing and stressful times. Our main aims are: Aim 1: To explore the effects of PARK on anxiety, depression, feelings of social isolation, positive affect, and a sense of meaning and purpose. Aim 2: To test whether age or gender moderate the effects of the program.

AnxietyDepressionSocial Isolation

Northwestern University1,000 participantsStarted Apr 2020

Chicago, Illinois, United States

Integrating a Suite of Mental Health Apps for Depression in a Healthcare Setting

Memory and Fear Study (Fear of Memory Loss Study)

Positive Affect Regulation sKills at Northwestern University

Anxiety Trials in Other Cities

Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Tracking Mood and Language Change Across a Phone-based Mindfulness Intervention

IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression

Discharge Functional Status and Rehospitalization in the Elderly

TODAY! A Mobile App Study

Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline

The Impact of a School-Based, Trauma-Informed CBT Intervention for Young Women

Sleep Quality, Heart Rate Variability and Anxiety Following Brain Injury

Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications

Anxiety Reduction During Office Procedural Medicine Using Aromatherapy

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

Online Multi-component Psychological Intervention for Depression, Anxiety and Well-being in 7 Countries

Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.

Long-Term Retention of Gadolinium in Bone

Other Conditions in Chicago